Use of sulfated oligosaccharides in the manufacture of a medicament for the treatment of patients with hepatocellular carcinoma after surgical resection

摘要

Reduce intrahepatic tumor recurrence and disease-free in HCC patients with microvascular involvement after curative liver resection, excluding hepatocellular carcinoma (HCC) patients without vascular involvement and HCC patients with macrovascular involvement Provided is the use of a sulfated oligosaccharide in the manufacture of a medicament for increasing the disease-free survival period.